Elevance Health, Inc. (NYSE:ELV – Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 3,630,000 ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per ...

Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Elevance Health in a research ...

A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...

The Indianapolis-based company said it had net income of $1.81 per share. Earnings, adjusted for one-time gains and costs, came to $3.84 per share. The results beat Wall Street expectations. The ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

Health-care companies rose sharply amid strong earnings.

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

Elevance Health Inc (ELV) stock saw a decline, ending the day at $400.96 which represents a decrease of $-0.40 or -0.10% from the prior close of $401.36. The stock opened at $397.16 and touched a low ...